Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
5
×
national blog main
boston blog main
boston top stories
clinical trials
deals
fda
national top stories
new york blog main
san diego blog main
san diego top stories
amgen
boston
new york top stories
novartis
rare diseases
startups
the medicines company
abbvie
achaogen
adams street partners
adverum biotechnologies
albert bourla
alirocumab
ally bridge group
alnylam pharmaceuticals
alzheimer's disease
amicus therapeutics
antibiotics
arvinas
batten disease
bayer
beta lactamase inhibitor
big data analytics
biogen
biomedical advanced research and development authority (barda)
biotech ipos
blackrock
boulder/denver blog main
What
company
5
×
drug
5
×
medicines
bio
brings
genetic
ipo
million
new
raised
therapeutics
acquire
acquisitions
agreed
albert
analysis
bacteria
biggest
billion
biopharma
biotech
bourla
bring
business
cash
ceo
cholesterol
compound
crispr
deal
develop
developing
disease
diseases
disorders
dyne
dyne’s
employing
exited
fda
Language
unset
unknown
Current search:
drug
×
" life sciences "
×
company
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections